Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Resulax is an over‑the‑counter laxative product used for short‑term relief of acute, occasional constipation and related symptoms such as abdominal discomfort and difficulty with bowel movements. It is formulated to act locally in the bowel to increase stool water content and promote bowel evacuation, typically producing a bowel movement within a relatively short time after rectal use. Detailed composition, molecular target, and advanced pharmacologic characteristics are not clearly specified in publicly available references, and Resulax is generally treated as a non‑specialty constipation remedy rather than a mechanistically targeted therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Resulax.